New York Professional Events List


International Conference on Neurology & Mental Disorders (CSE) AS


Date
Apr 11, 2019 - 08:00 AM - Apr 12, 04:00 PM
Organizer
conference series
Venue
Venue to be announced
Location
Venue will be informed to the Registered Participant,

Stockholm,
Stockholm,
Sweden,
ZIP: 00000
Phone:

International Conference on Neurology & Mental Disorders

 

About Conference:

What is Neurology and How is it related to Mental Disorders?? Many scientists say that Neurology is the branch of medicine concerned with the study and treatment of disorders of the nervous system. It is related to neurology as a behavioral or mental pattern that causes significant distress or impairment of personal functioning. To know more what people say we cordially invite you to the “International conference on Neurology and Mental Disorders “which is organized and hosted by Conference Series in the month of April from 11th – 12th, 2019 at Stockholm, Sweden. Conference Series is a platform which is organizes 3000+ plus International events where 800+ conferences are being organized across the globe. With a great pleasure we announce this conference where the theme of the conference mainly focuses on Neurology and Mental Disorders. We look forward to welcome you to Sweden Abstract Eligibility Criteria AUTHOR ELIGIBILITY: · Individuals may submit up to two regular abstracts as the first author. · Individuals may submit an unlimited number of Trials in Progress abstracts. · Individuals may serve as a coauthor on an unlimited number of abstracts. ABSTRACT ELIGIBILITY · All types of Psychology, Psychiatry, Mental Health research are eligible for submission. · Abstract should address scientific questions, detail clinical observations, or contain primary scientific data. · Data from the long-term follow-up of previously presented clinical trials may be submitted only if significant new information can be shown. · Interim analysis of a prospective randomized clinical trial will be considered if it is performed as planned in the original protocol and is statistically valid. · Abstracts of clinically-related subjects should be combined into a single abstract. Please Note: Submission of multiple abstracts on a single study may result in the rejection of one or more abstracts.

 

Scientific Sessions:

Session on : Neurology Neurology is a branch of medicine dealing with disorders of the nervous system. Neurology deals with the diagnosis and treatment of all categories of conditions and disease involving the central and peripheral nervous systems (and their subdivisions, the autonomic and somatic nervous systems), including their coverings, blood vessels, and all effector tissue, such as muscle. Session on: Neurological Disorders Neurological disorders are diseases of the brain, spine and the nerves that connect them. There are more than 600 diseases of the nervous system, such as brain tumors, Parkinson's disease as well as less familiar ones such as frontotemporal dementia. Session on: Stroke Stroke is a medical condition in which poor blood flow to the brain results in cell death. There are two main types of stroke: ischemic, due to lack of blood flow, and hemorrhagic, due to bleeding. Session on: Dementia Dementia is not a specific disease. It's an overall term that describes a wide range of symptoms associated with a decline in memory or other thinking skills severe enough to reduce a person's ability to perform everyday activities. Session on: Alzheimer’s Disease Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia. Session on: Epilepsy Epilepsy is a group of neurological disorders characterized by epileptic seizures. Epileptic seizures are episodes that can vary from brief and nearly undetectable periods to long periods of vigorous shaking. These episodes can result in physical injuries, including occasionally broken bones. In epilepsy, seizures tend to recur and, as a rule, have no immediate underlying cause. Isolated seizures that are provoked by a specific cause such as poisoning are not deemed to represent epilepsy. People with epilepsy in some areas of the world experience varying degrees of social stigma due to their condition. Session on: Neuroimaging and Radiology What seems astonishing is that engineering techniques like brain engineering, or Neural tissue engineering can be used to understand, repair, replace, enhance, or otherwise exploit the properties of neural systems and Neuro computing is the study of brain function in terms of the information processing properties of the structures that make up the nervous system. current researches in the field of neuro engineering include: Neural imaging and neural networking, Biomolecular therapies in neural regeneration, Neurorobotics, Biological neural networking. Session on: Spine Disorders The most imperative side effect for the dominant part of spinal issue is torment. Spine is very mind-boggling structure with various capacities. Ordinary maturing process prompts changes in vertebrae, tendons and intervertebral circles. Osteoporosis frequently happens in ladies after menopause and other hazard variables can prompts debilitating of bone; smoking, unreasonable liquor utilization, radiation treatment of spine, a long-haul treatment with cortisone or end organize liver and renal infection. Session on: Mental Illness A mental disorder, also called a mental illness or psychiatric disorder, is a behavioral or mental pattern that causes significant distress or impairment of personal functioning. Such features may be persistent, relapsing and remitting, or occur as a single episode. Many disorders have been described, with signs and symptoms that vary widely between specific disorders. Such disorders may be diagnosed by a mental health professional. Session on: Types of Mental Health

Mental health is defined as a state of well-being in which every individual realizes his or her own potential, can cope with the normal stresses of life, can work productively and fruitfully, and is able to contribute to her or his community. Mental Health incorporates a person's capability to appreciate life and make a harmony between ordinary life exercises and endeavors to accomplish mental flexibility. Mental health conditions can cause distress, impact on day-to-day functioning and relationships, and are associated with poor physical health and premature death from suicide. It is essential at each phase of life one should maintain good mental wellbeing. Session on: Depression It is the act of intentionally causing one's own death. Risk factors Include mental disorders like depression, stress, anxiety, bipolar disorder, schizophrenic psychosis, personality disorders, alcoholism, substance misuse, and use of benzodiazepines. Other issues may include impulsive acts due to stress such as financial problems, workplace Stress, troubles with relationships or from bullying. Those who have previously attempted suicide those are at higher risk for future attempts. Suicide prevention efforts include limiting access to methods of suicide, such as firearms, drugs, and poisons, treating mental disorders and substance misuse, proper media reporting of suicide, and improving economic conditions. Session on: Eating Disorders An eating disorder is a mental disorder defined by abnormal eating habits that negatively affect a person's physical or mental health. They include binge eating disorder where people eat a large amount in a short period of time, anorexia nervosa where people eat very little and thus have a low body weight, bulimia nervosa where people eat a lot and then try to rid themselves of the food, pica where people eat non-food items, rumination disorder where people regurgitate food, avoidant/restrictive food intake disorder where people have a lack of interest in food, and a group of other specified feeding or eating disorders. Session on: Schizophrenia Schizophrenia is a mental disorder characterized by abnormal social behavior and failure to understand reality. Common symptoms include false beliefs, unclear or confused thinking, hearing voices that others do not, reduced social engagement and emotional expression, and a lack of motivation. People with schizophrenia often have additional mental health problems such as anxiety, depressive, or substance-use disorders. Symptoms typically come on gradually, begin in young adulthood, and last a long time. Session on: Anxiety Disorder Anxiety disorders are a group of mental disorders characterized by significant feelings of anxiety and fear. Anxiety is a worry about future events and fear is a reaction to current events. These feelings may cause physical symptoms, such as a fast heart rate and shakiness. There are many anxiety disorders: including generalized anxiety disorder, specific phobia, social anxiety disorder, separation anxiety disorder, agoraphobia, panic disorder, and selective mutism. The disorder differs by what results in the symptoms. People often have more than one anxiety disorder. Session on: Chronic Mental Illness Depression caused by chronic disease often makes the condition worse, especially if the illness causes pain and fatigue or it limits a person's ability to interact with others. The combination of chronic illness and depression might lead you to isolate yourself, which is likely to make the depression even worse. Research on chronic illnesses and depression indicates that depression rates are high among patients with chronic conditions. Mental health is important at every stage of life.

AGENDA 2017 ----------------------------------- 2018 Upcoming Soon ----------------------------------- ----------------------------------------- 08:30-09:00 Registrations Burgos Day 1 | March 27, 2017 ----------------------------------------- Special Session 11:50-12:40 Title: Neurofeedback: An alternative vision in the treatment of neurological and neuropsychiatric disorder Jyri Kuusela, Clinical Hospital San Carlos, Spain Sessions: Neurology and Neuroimmunology Session Introduction @ 12:40-12:45 Session Chair: Harish C Pant, National Institutes of Health, USA Session Chair: Corina O Bondi, University of Pittsburgh, USA 12:45-13:15 Title: Effects of chronic unpredictable stress on cognitive and depressive-like behaviors following experimental brain trauma Corina O Bondi, University of Pittsburgh, USA Networking & Refreshment Break: 13:15-14:00 @ Zamora 14:00-14:30 Title: The Think Fast Study – A randomized controlled study to improve speed of processing in adults with HIV-associated neurocognitive disorder David E Vance, University of Alabama at Birmingham, USA 14:30-15:00 Title: Repurposing the NRF2 activator dimethyl fumarate as therapy against synucleinopathy in Parkinson’s disease Isabel Lastres-Becker, Autonomous University of Madrid, Spain 15:00-15:30 Title: Effectiveness of fingolimod in patients with relapsing-remitting multiple sclerosis in daily clinical practice in Spain: Results from a multivariate pool analysis called Fingoview Irene Sanchez-Vera, Novartis Farmaceutica S.A., Spain Session Conclusion Networking & Refreshment Break: 15:30-15:50 @ Zamora Workshop on “Chasing the neuron: Central to peripheral” Session Chair: Vahe Poghosyan, King Fahad Medical City, Saudi Arabia 15:50-16:20 Title: Functional neuroimaging of language and memory using magnetoencephalography (MEG) Vahe Poghosyan, King Fahad Medical City, Saudi Arabia 16:20:16:50 Title: Impact of Neuronavigation on Neurosurgical practice Lahbib Soualmi, King Fahad Medical City, Saudi Arabia 16:50:17:20 Title: Intra-operative neurophysiologic Monitoring: Current advance and future potential Elamir Elsherif, King Fahad Medical City, Saudi Arabia 17:20:17:50 Title: Electrodiagnosis of the peripheral Nerve Sajjad Ali, King Fahad Medical City, Saudi Arabia Keynote Forum 09:00-09:30 Keynote Forum 09:30-10:10 Title: Novel basic cell biological approaches to prevent the neuropathological disease symptoms and behavior Harish C Pant, National Institutes of Health, USA 10:10-10:50 Title: Comprehensive stroke care in the rural setting is not a myth Evelyn M Garcia, Carilion Clinic, USA Networking & Refreshment Break: 10:50-11:10 @ Zamora 11:10-11:50 Title: Therapeutic interventions after experimental brain trauma: The good and the not-so-good Anthony E Kline, University of Pittsburgh, USA -------------------------------------- Day 2 | March 28, 2017 Burgos -------------------------------------- Keynote Forum 09:30-10:10 Title: Behavioral engagement, Brain fitness, and cognitive functioning across the lifespan: Clinical and research highlights David E Vance, University of Alabama at Birmingham, USA 10:10-10:50 Title: Magnetoencephalography (MEG) in neurology Vahe Poghosyan, King Fahad Medical City, Saudi Arabia Networking & Refreshment 10:50-11:10 @ Zamora Sessions: CNS, Clinical Neurology and Neuropsychiatry Session Introduction @ 11:10-11:15 Session Chair: Ana Frances, Institut d’Investigació Sanitària Pere Virgili (IISPV), Spain Session Chair: Chair: Saba Nia, Kaiser Franz Josef Spital, Austria 11:15-11:45 Title: Structural heart disease, minimally invasive procedures and the relationship to thromboembolic cerebral disease Evelyn M Garcia, Carilion Clinic, USA 11:45:12:15 Title: Aripiprazole does not attenuate the benefits of environmental enrichment after experimental brain trauma Anthony E Kline, University of Pittsburgh, USA 12:15-12:45 Title: Diffusion tensor tractography of memory-related white matter tracts in amyotrophic lateral sclerosis Zoi A Giavri, Advantis Medical Imaging, Greece Lunch Break: 12:45-13:30 @ Zamora 13:30-14:00 Title: Neuropsychiatric signs and symptoms in treatable inborn errors of metabolism Saba Nia, Kaiser Franz Josef Spital, Austria 14:00-14:30 Title: Stroke endovascular treatment: Efficacy and security analysis with the time of development Joaquin Carneado-Ruiz, Hospital Universitario Puerta de Hierro, Spain Sessions: Neurotherapeutics and Case Studies Session Introduction @ 14:30-14:35 Session Chair: Anthony E Kline, University of Pittsburgh, USA Session Chair: Chair: Aziza Al-Rafiah, King Abdul Aziza University, Saudi Arabia 14:35-15:05 Title: Pro-inflammatory cytokine il-1 in central nervous and reproductive systems in multiple sclerosis female patients: Communication between nervous, endocrine and immune systems Ana Frances, Institut d’Investigació Sanitària Pere Virgili (IISPV), Spain 15:05-15:35 Title: Heterotopic and homotopic effects of acupuncture on pain modulation share different story Xinyan Gao, China Academy of Chinese Medical Sciences, China Networking & Refreshment 15:35-15:55 @ Zamora 15:55-16:25 Title: Plastin3 as a therapeutic target in spinal muscular atrophy Aziza Al-Rafiah, King Abdul Aziza University, Saudi Arabia 16:25-16:55 Title: Locked in syndrome: A case report Jalellah B Noor, Ospital ng Makati, Philippines 16:55-17:25 Title: Reliability and validity of the alberta infant motor scale thai version Piyapong Aimsamrarn, Khon Kaen University, Thailand Poster Presentations: 17:25-18:00 @ Zamora Sessions: Session Judge: Harish C Pant, National Institutes of Health, USA/Evelyn M Garcia, Carilion Clinic, USA NEU 01 Title: HIV-associated neurocognitive disorder: How useful is the diagnosis? David E Vance, University of Alabama at Birmingham, USA NEU 02 Title: Budget implications for the UK NHS of implementing mechanical thrombectomy for the treatment of acute Ischemic stroke patients: Calculation with the solitaireTM revascularization device Pablo Guijarro, Medtronic Ibérica, Spain NEU 03 Title: A voice for Epilepsy Ann Marie Gillie, Epilepsy Advocate, Canada NEU 04 Title: Turnings in Parkinsons disease Khin Bo, Northern Lincolnshire and Goole Hospitals NHS Foundation Trust, UK NEU 05 Title: Efficacy of a fatigue management intervention in Multiple Sclerosis patients Marta Parreira, University of Minho, Portugal NEU 06 Title: Reliability and validity of the alberta infant motor scale thai version Piyapong Aimsamrarn, Khon Kaen University, Thailand NEU 07 Title: Bradykinin reverts contralateral rotation and restores dopamine levels in an animal model of Parkinson disease Héllio Danny Nóbrega de Souza, Universidade de São Paulo, Brazil NEU 08 Title: Antidepressant-like effects of medicinal herb extract in a chronic stress mouse model of depression Mi Young Lee, Korea Institute of Oriental Medicine, Korea ------------------------------------- Day 3 | March 29, 2017 Burgos ------------------------------------- Sessions: Neurodegenerative and Neuromuscular Disorders Session Introduction @ 09:25-09:30 Session Chair: Joaquin Carneado-Ruiz, Hospital Universitario Puerta de Hierro, Spain Session Chair: Chair: Xinyan Gao, China Academy of Chinese Medical Sciences, China 9:30-10:00 Title: Multiple Sclerosis, corpus callosum and bedside test Khin Bo, Northern Lincolnshire and Goole Hospitals NHS Foundation Trust, UK 10:00-10:30 Title: The meaningfulness of cognitive processing speed in the assessment of cognitive impairment Judit Subirana-Mirete, Ramon Llull University, Spain Networking & Refreshment 10:30-10-50 @ Zamora 10:50-11:20 Title: Psychological and emotional problems in adolescents with Epilepsy Maia Machvariani-Tsereteli, Ivane Javakhisvili Tbilisi State University, Georgia 11:20-11:50 Title: Efficacy of a fatigue management intervention in multiple sclerosis patients Marta Parreira, University of Minho, Portugal 11:50-12:20 Title: A Voice for Epilepsy Ann Marie Gillie, Epilepsy Advocate, Canada 12:20-12:50 Title: Innovation in the physiotherapy treatment of Parkinson’s disease Selma Pelaez, UManresa-FUB, Spain Lunch Break: 12:50-13:30 @ Zamora Young researcher forum 13:30-13:50 Title: Neuroprotective effect of cathechins gambier on beta amyloid plasma and cognitive in dawley sprague as model of Alzheimer Linda Rosalina, Padang State University, Indonesia 13:50-14:10 Title: Blockage of system xc- Improves cocaine addiction in cocaine-dependence mice Vivian Hsu, China Medical University, Taiwan 14:10-14:30 Title: Novel psychoactive substance (NPS): Effects of the 5-IT and D2PM on the dopamine system and 5-HTA, 5-HTC receptors site Zia-Uddin Ahmed, University of Roehampton, UK Award Ceremony and Finishing Note @ 14:30-14:35

 

Please contact the event manager Marilyn ([email protected] ) below for:

- Multiple participant discounts - Price quotations or visa invitation letters - Payment by alternate channels (PayPal, check, Western Union, wire transfers etc) - Event sponsorships NO REFUNDS ALLOWED ON REGISTRATIONS Service fees included in this listing. ----------------------------------------------------------------- This event is brought to you by: Conference Series - NewYorkEventsList http://www.NyEventsList.com http://www.BostonEventsList.com http://www.SFBayEventsList.com ----------------------------------------------------------------- MYL180604CEV MYL180627UPA VIO180925UPD


Event Categories
Healthcare
Keywords: fun, analysis, access , arts, assessment , Clinical , communication , community , conference , development




Comments








Events Calendar

SunMonTueWedThuFriSat
31 1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 1 2 3 4

Newsletters

Subscribe
VIP Life Time Subscription to our Newsletters!
$399.99
$299.99

Forbes Women's Summit 2018
Disrupt SF 2018 - Brought to you by Techcrunch
U.S. Naval Institute Annual Meeting 2018
Breast Cancer Research Foundation
Children’s Health Fund
The World Energy Engineering Congress (WEEC)
                            Oct. 17-19, 2018
                            Charlotte, NC